Global Digital Pathology 2019
What You Need to Know to Get Started

Author
Eder Lagemann

Author
Jonathan Christensen

January 9, 2020 | Read Time: 6 minutes

Around the world—from Asia, to Europe, to Canada, to the United States—healthcare organizations have begun to use digital pathology technology for primary diagnostic work, not just research (for which digital pathology has been used for nearly a decade). Depending on your organization, moving to a digital pathology solution may not save you money, but it can result in benefits like improved quality and flexibility for remote reading, and it will lay the groundwork for telepathology capabilities that can help your organization deal with pathologist shortages predicted for the future.

KLAS interviewed a number of leading organizations using digital pathology solutions for primary diagnosis, focusing on reference sites from vendors in the US and Europe, to highlight what healthcare organizations need to know to get started with digital pathology.

to see the full dataset.

if you don't have a login, getting started is easy.

Provider Organizations

Fill out our registration form to verify your organization.

Provider Registration

HIT Companies

Contact a KLAS representative for plans and pricing.

Contact KLAS

Key Findings

Digital Pathology Ecosystem
Vendor Performance
Early Entrant Philips Leading the Digital Pathology Market
Sectra Leveraging Radiology PACS Expertise to Grow in Digital Pathology
Leica, Other Pathology PACSs Struggling to Gain Ground
What You Need to Know about Digital Pathology Solutions
Getting Started
Benefits, ROI, and the Future State of Digital Pathology

Writer
Amanda Wind Smith

Designer
Madison Fujimoto

Download Report Brief Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.